Peyrat, G.; Bournez, C.; Krezel, P.; Gally, J.-M.; Bourg, S.; Aci-Sèche, S.; Bonnet, P.
Frags2Drugs: A Novel In Silico Fragment-Based Approach to the Discovery of Kinase Inhibitors. Pharmaceuticals 2026, 19, 308.
https://doi.org/10.3390/ph19020308
AMA Style
Peyrat G, Bournez C, Krezel P, Gally J-M, Bourg S, Aci-Sèche S, Bonnet P.
Frags2Drugs: A Novel In Silico Fragment-Based Approach to the Discovery of Kinase Inhibitors. Pharmaceuticals. 2026; 19(2):308.
https://doi.org/10.3390/ph19020308
Chicago/Turabian Style
Peyrat, Gautier, Colin Bournez, Pascal Krezel, José-Manuel Gally, Stéphane Bourg, Samia Aci-Sèche, and Pascal Bonnet.
2026. "Frags2Drugs: A Novel In Silico Fragment-Based Approach to the Discovery of Kinase Inhibitors" Pharmaceuticals 19, no. 2: 308.
https://doi.org/10.3390/ph19020308
APA Style
Peyrat, G., Bournez, C., Krezel, P., Gally, J.-M., Bourg, S., Aci-Sèche, S., & Bonnet, P.
(2026). Frags2Drugs: A Novel In Silico Fragment-Based Approach to the Discovery of Kinase Inhibitors. Pharmaceuticals, 19(2), 308.
https://doi.org/10.3390/ph19020308